About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,670 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,670 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 28,670 trials

CompletedHatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer SurvivorsRATIONALE: Yoga may improve inflammation, fatigue, and depression in female breast cancer survivors.NCT00486525·Columbus, Ohio CompletedOpen-label Extension to Protocol 1042-0600To allow open-label extension to patients who have completed Protocol 1042-0600.NCT00512317·Birmingham, Alabama and 24 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedStudy of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaThe primary objective of this study is to investigate the efficacy of levalbuterol 90 ug (2 actuations, 45 ug each) versus placebo (2 actuations) in the treatment and prevention…NCT00073840·Oxford, Alabama and 53 others

CompletedStudy of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)The purpose of this study was to evaluate the effects of semaglutide on intra-hepatic triglyceride (IHTG) content in people living with HIV (PLWH), central adiposity, insulin…NCT04216589·Birmingham, Alabama and 8 others

CompletedConcussion Symptom Treatment and Education Program (C-STEP) in Post-Concussion SyndromeThis prospective randomized intervention study aims to determine if the Concussion Symptom Treatment Program (C-STEP), a cognitive behavioral therapy, improves outcomes for…NCT04111991·Columbus, Ohio

CompletedSPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainThe purpose of this study is to determine the benefit and safety of relugolix 40 milligrams (mg) once daily, co-administered with low-dose estradiol (E2) and norethindrone acetate…NCT03204318·Dothan, Alabama and 122 others

CompletedAnti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic MelanomaThis Phase II study is designed to evaluate the anti-tumor activity of three dose groups of SB-485232 (0.01, 0.1, and 1.0 mg/kg/day) administered intravenously as a single agent…NCT00107718·Los Angeles, California and 19 others

CompletedStudy to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract SurgeryThe study is a prospective, randomized, parallel-design, multicenter trial in patients ≥40 years of age undergoing cataract surgery.NCT02547623·Glendora, California and 10 others

RecruitingEPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth spectrum (PROS).NCT06997588·St Louis, Missouri and 38 others

CompletedHemophilia Inhibitor Previously Untreated Patient StudyHemophilia A is a congenital bleeding disorder caused by deficiency of factor VIII (FVIII) and is treated by replacement therapy with FVIII concentrate.NCT01652027·Atlanta, Georgia and 16 others

Active not recruitingFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentThis research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment.NCT03516942·Anchorage, Alaska and 715 others

CompletedBreathID 13C-Methacetin Breath Test for Detecting CirrhosisThis trial is a pivotal trial to validate the use of a 13 C labeled substrate called methacetin and the BreathID automatic breath testing system, for determination of cirrhosis in…NCT00736840·Los Angeles, California and 10 others

CompletedVEC-162 Study in Adult Patients With Primary InsomniaThe purpose of this study is to evaluate the efficacy and safety of a 5 week double-blind treatment period of VEC-162 as compared to placebo in male and female patients with…NCT00548340·Birmingham, Alabama and 34 others

CompletedgB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent FemalesThe purpose of this research study is to test the safety of and the body's response to an experimental cytomegalovirus (CMV) vaccine (called gB/MF59 vaccine).NCT00133497·Cincinnati, Ohio and 4 others

RecruitingComparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialThis phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug…NCT04510597·Birmingham, Alabama and 386 others

TerminatedA Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or AdalimumabThis is a Phase II, randomized, active-controlled, double-blind, double-dummy, parallel-group, multicenter study in the United States enrolling patients with active RA.NCT00808210·Birmingham, Alabama and 52 others

CompletedStudy Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's DiseaseThe purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to…NCT00277810·Phoenix, Arizona and 82 others

CompletedEvaluation of the EasySense System in Congestive Heart FailureThe EasySense device is a non-invasive device designed to measure lung fluid in patients with Congestive Heart Failure (CHF).NCT03237923·Columbus, Ohio

Enrolling by invitationTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)To evaluate the long-term safety and tolerability of sibeprenlimab in subjects with IgANNCT05248659·Birmingham, Alabama and 157 others

RecruitingMOTION Clinical TrialProspective, multicenter, two-arm, 2:1 randomized controlled trial (RCT) comparing the benefits in subjects with medial knee osteoarthritis who are treated with either the MISHA…NCT06843980·Davis, California and 8 others

PreviousPage 18 of 1434Next

Heart Diseasein Ohio